Home/Synapse Biomedical/Anthony R. Ignagni

AR

Anthony R. Ignagni

President & CEO

Synapse Biomedical

Therapeutic Areas

Respiratory Insufficiency Spinal Cord Injury Amyotrophic Lateral Sclerosis (ALS)

Synapse Biomedical Pipeline

Drug	Indication	Phase
NeuRx DPS	Respiratory insufficiency in Spinal Cord Injury & ALS	Approved
TransAeris System	Prevention/Treatment of Ventilator-Induced Diaphragm Dysfunction (VIDD)	Approved

Leadership Team at Synapse Biomedical

Chief Operating Officer & Managing Director-Europe

View full Synapse Biomedical profile